TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31408531

Group type: EXPERIMENTAL
Intervention: MYC translocation (n = 42)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Double-hit translocation (n = 31)
Number of subjects: 130

Group type: COMPARATOR
Intervention: No MYC translocation (n = 35)
Number of subjects: 130

Group type: COMPARATOR
Intervention: No double-hit translocation (n = 46)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: MYC translocation
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Double-hit translocation
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Non-germinal centre type
Number of subjects: 130
Study: 28334771

Group type: EXPERIMENTAL
Intervention: Degarelix 360 mg every 84 days
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Degarelix 480 mg every 84 days
Number of subjects: 155
Study: 25287168

Group type: EXPERIMENTAL
Intervention: 280 mg of acid‐resistant lipase
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 23877927

Group type: EXPERIMENTAL
Intervention: 5% glucose solution
Number of subjects: 87

Group type: COMPARATOR
Intervention: saline
Number of subjects: 87
Study: 21471801

Group type: EXPERIMENTAL
Intervention: Active subdiaphragmatic gas aspiration (n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Simple evacuation (n=52)
Number of subjects: 104
Study: 18535812

Group type: EXPERIMENTAL
Intervention: SCIT (Subcutaneous Immunotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SLIT (Sublingual Immunotherapy)
Number of subjects: 0
Study: 16582575

Group type: EXPERIMENTAL
Intervention: Cystatin C serum levels
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inulin clearance
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Serum creatinine levels
Number of subjects: 41
Study: 12546249

Group type: EXPERIMENTAL
Intervention: Freshly prepared foods (15 MJ, 3,600 kcal)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Full CRP (15 MJ, 3,600 kcal)
Number of subjects: 33

Group type: COMPARATOR
Intervention: One-half CRP (7.5 MJ, 1,800 kcal)
Number of subjects: 33
Study: 11789206

Group type: EXPERIMENTAL
Intervention: Astragalus plus ligustrazine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Astragalus
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ligustrazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 8903697

Group type: EXPERIMENTAL
Intervention: Isometric arm exercises
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Scapular plane arm elevation and arm abduction
Number of subjects: 6
Study: 2052117

Group type: EXPERIMENTAL
Intervention: Lithium aspartate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6139628

Group type: EXPERIMENTAL
Intervention: Vitamin D or alfacalcidol treatment; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference range based on biochemical measurements and biopsy results; no specific control group mentioned.
Number of subjects: 0
Study: 31192938

Group type: EXPERIMENTAL
Intervention: 3-row circular stapler (Mirus Disposable Circular Stapler 3 Row 29)
Number of subjects: 154

Group type: COMPARATOR
Intervention: 2-row circular stapler (Ethicon 29 mm Curved Intraluminal Stapler)
Number of subjects: 154
Study: 28146245

Group type: EXPERIMENTAL
Intervention: AFXL pretreatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Microdermabrasion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-AFXL pretreatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Methyl aminolevulinate-treated controls
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 12
Study: 25574609

Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting digit flexors (DF)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting elbow flexors (EF)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting lumbar flexors (LF)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting shoulder adductors (SA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control climb (no prefatiguing exercise)
Number of subjects: 11
Study: 25311158

Group type: EXPERIMENTAL
Intervention: NHP (medicinal herb-based natural health product)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (negative control)
Number of subjects: 30
Study: 22476240

Group type: EXPERIMENTAL
Intervention: Pregabalin (100 mg preoperatively, then 50 mg every 12 hrs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19608565

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) for final oocyte maturation
Number of subjects: 0

Group type: COMPARATOR
Intervention: hCG for final oocyte maturation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Luteal phase rescue with GnRHa
Number of subjects: 0
Study: 17890944

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy without thalidomide
Number of subjects: 668

Group type: COMPARATOR
Intervention: Chemotherapy with thalidomide
Number of subjects: 668
Study: 15375808

Group type: EXPERIMENTAL
Intervention: Mental imagery program
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional functional training intervention
Number of subjects: 46
Study: 11124927

Group type: EXPERIMENTAL
Intervention: Automatic incision device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional manual lancet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 11511333

Group type: EXPERIMENTAL
Intervention: Activated protein C (APC)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Pain management techniques
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Novel markers of neurotrauma
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Antioxidants in bypass surgery
Number of subjects: 500
Study: 9262046

Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 8316266

Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Coronary angioplasty
Number of subjects: 1012
Study: 2436415

Group type: EXPERIMENTAL
Intervention: 3% dithranol sticks (Ditrastick)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4% butantrone sticks
Number of subjects: 30
Study: 30360635

Group type: EXPERIMENTAL
Intervention: FAST Club physical activity intervention (2 sessions/week for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study: 27525826

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment for 4 weeks, using two acupoints: Baihui and Shenting
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified what treatment they received)
Number of subjects: 61
Study: 24566820

Group type: EXPERIMENTAL
Intervention: Web-based multiple health behavior change program
Number of subjects: 352

Group type: COMPARATOR
Intervention: Delayed-treatment control condition
Number of subjects: 352
Study: 22197012

Group type: EXPERIMENTAL
Intervention: Semi-recumbent position (30°)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 229
Study: 20192923

Group type: EXPERIMENTAL
Intervention: Chromogranin A detection in saliva of type 2 diabetic patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 60
Study: 18462423

Group type: EXPERIMENTAL
Intervention: IPL plus BTX (8 U total dose, 0.1 mL intradermal injections in one cheek)
Number of subjects: 15

Group type: COMPARATOR
Intervention: IPL plus saline (control group)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IPL plus BTX
Number of subjects: 15

Group type: COMPARATOR
Intervention: IPL plus saline
Number of subjects: 15
Study: 16378562

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug treatment
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: No modifications to drug treatment
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Number of antihypertensive drugs taken
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Number of antihypertensive drug modifications
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Clinician contacts
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Hypertension-related consultations
Number of subjects: 560
Study: 12634972

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10576361

Group type: EXPERIMENTAL
Intervention: Surgical prosthesis coupled to an anti-reflux valve system (group 2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Esophageal prosthesis without anti-reflux valve mechanism (group 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 22
Study: 8629830

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant therapies (not specified)
Number of subjects: 0
Study: 1670907

Group type: EXPERIMENTAL
Intervention: Upright tilt-table test with isoproterenol infusion (1 to 3 micrograms/minute)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Therapy with beta-blockers, disopyramide, transdermal scopolamine, or hydroflurocortisone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study: 31132897

Group type: EXPERIMENTAL
Intervention: Topical 0.25% desoximetasone spray with twice daily phone call reminders
Number of subjects: 12
Study: 29374668

Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership (NFP) plus existing services
Number of subjects: 400

Group type: COMPARATOR
Intervention: Existing services (comparison group)
Number of subjects: 400
Study: 26956140

Group type: EXPERIMENTAL
Intervention: SEE IT training during three outpatient SPI visits over a 1-month period
Number of subjects: 52

Group type: COMPARATOR
Intervention: Single SPI visit with a diabetes treatment video
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: SEE IT training
Number of subjects: 52
Study: 24052275

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22416902

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 66
Study: 20077249

Group type: EXPERIMENTAL
Intervention: Biologic product before manufacturing change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biologic product after manufacturing change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional statistical methods (two one‐sided testing, Kolmogorov‐Smirnov test)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overlap coefficient method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regulatory considerations
Number of subjects: 0
Study: 18230864

Group type: EXPERIMENTAL
Intervention: Honey-thickened liquids
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Nectar-thickened liquids
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Chin-down posture
Number of subjects: 711
Study: 17196058

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 or 20 mg/day)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 15493437

Group type: EXPERIMENTAL
Intervention: Visual attention therapy (12 one-hour sessions, computer-based)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 30
Study: 11101481

Group type: EXPERIMENTAL
Intervention: Phylloquinone (1000 microg daily for 2 weeks)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 8956929

Group type: COMPARATOR
Intervention: Tiagabine (30 mg/day)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Tiagabine (mean 65.7 mg/day, range 30-80 mg/day)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Tiagabine (mean 67.6 mg/day, range 24-80 mg/day)
Number of subjects: 37
Study: 1488558

Group type: EXPERIMENTAL
Intervention: RU 41740 long-term treatment for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: RU 41740 standard treatment for 3 months
Number of subjects: 40
Study: 3994008

Group type: EXPERIMENTAL
Intervention: Lidocaine in dextrose
Number of subjects: 2

Group type: COMPARATOR
Intervention: Lidocaine in dextrose plus epinephrine
Number of subjects: 2
Study: 31437659

Group type: EXPERIMENTAL
Intervention: Nicotine lozenge before training sessions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo lozenge before training sessions
Number of subjects: 25
Study: 29257986

Group type: EXPERIMENTAL
Intervention: High n-3 LCPUFA marine fish intake
Number of subjects: 0
Study: 27772558

Group type: EXPERIMENTAL
Intervention: Collaborative group intervention (CGI) with 10 group sessions over 3 months and 2 booster sessions at 6 and 12 months after baseline.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Enhanced medical care (control group).
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Collaborative group intervention (CGI).
Number of subjects: 300
Study: 24650860

Group type: EXPERIMENTAL
Intervention: Sequential intervention (n=552)
Number of subjects: 1733

Group type: EXPERIMENTAL
Intervention: Simultaneous intervention (n=517)
Number of subjects: 1733

Group type: COMPARATOR
Intervention: Control condition (n=664)
Number of subjects: 1733
Study: 22529255

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT) with fluorouracil (FU)
Number of subjects: 823

Group type: COMPARATOR
Intervention: Postoperative chemoradiotherapy (CRT) with fluorouracil (FU)
Number of subjects: 823
Study: 19793169

Group type: EXPERIMENTAL
Intervention: 1 liter PEG with 200 mg dimethylpolysiloxane 3 hours before CE
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fasted only
Number of subjects: 40
Study: 18579907

Group type: EXPERIMENTAL
Intervention: Maximum dorsiflexor moment during walking at increasing speeds (70, 80, 90, 100, and 110% of PTS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Transition from walking to running at the preferred transition speed (PTS)
Number of subjects: 16
Study: 15715188

Group type: EXPERIMENTAL
Intervention: Oral clarithromycin (Klaricid XL) once-daily for 3 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 11830814

Group type: EXPERIMENTAL
Intervention: Chondroplasty and electrocautery
Number of subjects: 146

Group type: COMPARATOR
Intervention: Chondroplasty alone (Control)
Number of subjects: 146
Study: 10090328

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (15 p.p.m.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (without inhaled nitric oxide)
Number of subjects: 9
Study: 7751833

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Buspirone (10 or 15 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-dose training phase
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Self-reported effects of diazepam
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Self-reported effects of buspirone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Self-reported effects of both drugs
Number of subjects: 19
Study: 2256458

Group type: EXPERIMENTAL
Intervention: Apple pollen extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Birch pollen
Number of subjects: 0
Study: 399857

Group type: EXPERIMENTAL
Intervention: Increasing weekly injections of house dust mite extract for 18 weeks followed by monthly injections to complete 18 months of treatment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Similar injections for 18 weeks followed by placebo injections up to 18 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo injections for 18 months
Number of subjects: 56
Study: 30919909

Group type: EXPERIMENTAL
Intervention: PCI with everolimus-eluting stents
Number of subjects: 1858

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (PMI)
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: Peak post-procedure CK-MB ≥10× URL
Number of subjects: 1858
Study: 27865639

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 4659

Group type: COMPARATOR
Intervention: Femoropopliteal bypass surgery (BPS)
Number of subjects: 4659

Group type: COMPARATOR
Intervention: Covered stent (CS)
Number of subjects: 4659

Group type: COMPARATOR
Intervention: Nitinol stent (NS)
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: Combination therapy of Nitinol stent (NS) with cryoplasty (CR) and drug-coated balloon
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon
Number of subjects: 4659

Group type: COMPARATOR
Intervention: Balloon angioplasty (BA)
Number of subjects: 4659

Group type: COMPARATOR
Intervention: Cryoplasty (CR)
Number of subjects: 4659
Study: 25986492

Group type: EXPERIMENTAL
Intervention: Simulation-based transesophageal echocardiography teaching via the Heartworks simulator (n = 12)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group receiving transesophageal echocardiography teaching during elective cardiac surgery (n = 13)
Number of subjects: 25
Study: 23504694

Group type: EXPERIMENTAL
Intervention: Daclatasvir (60 mg once daily) and asunaprevir (600 mg twice daily) for 24 weeks (Group A)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Daclatasvir (60 mg once daily) and asunaprevir (600 mg twice daily) with peginterferon alfa-2a and ribavirin for 24 weeks (Group B)
Number of subjects: 21
Study: 21674385

Group type: EXPERIMENTAL
Intervention: Time-independent functional training (TIFT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Time-dependent training (TD)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Visual demonstration
Number of subjects: 37
Study: 19622986

Group type: EXPERIMENTAL
Intervention: Induced patients with vaginal deliveries
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Multiparity
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Maternal BMI less than 30
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Height greater than 5'5"
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Baseline modified Bishop score of 4
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Birth weight below 4,000 g
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Maternal age younger than 35 years
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Hispanic race
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: African-American race
Number of subjects: 1274
Study: 16681537

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dissection tonsillectomy
Number of subjects: 20
Study: 12508046

Group type: EXPERIMENTAL
Intervention: Mandibular two-implant retained overdentures (IOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional complete dentures (CD)
Number of subjects: 60
Study: 10822744

Group type: EXPERIMENTAL
Intervention: School-based prevention program from the Alcohol Misuse Prevention Study (AMPS)
Number of subjects: 371
Study: 8857075

Group type: EXPERIMENTAL
Intervention: Rectal administration of budesonide (2 mg in 100 ml fluid)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Oral administration of budesonide (2 mg in gelatine capsule)
Number of subjects: 15
Study: 1517614

Group type: EXPERIMENTAL
Intervention: fenfluramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 6712030

Group type: EXPERIMENTAL
Intervention: Bovine heparin
Number of subjects: 86
Study: 30954378

Group type: EXPERIMENTAL
Intervention: Delefilcon A
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Somofilcon A
Number of subjects: 64
Study: 29879048

Group type: COMPARATOR
Intervention: Control (false TAES followed by saline injection after 30 minutes)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: TAES (TAES followed by saline injection after 30 minutes)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Sufentanil (false TAES followed by low‐dose sufentanil (0.1 μg/kg) injection after 30 minutes)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Sufentanil plus TAES (TAES followed by low‐dose sufentanil injection after 30 minutes)
Number of subjects: 172
Study: 27499187

Group type: EXPERIMENTAL
Intervention: Personalised nutrition (PN) advice
Number of subjects: 1480

Group type: COMPARATOR
Intervention: Control, non-personalised dietary intervention
Number of subjects: 1480
Study: 25027338

Group type: EXPERIMENTAL
Intervention: LigaSure® Vessel Sealing System (LVSS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional Clamp‐Tie (CT)
Number of subjects: 54
Study: 22182405

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 30
Study: 19467896

Group type: EXPERIMENTAL
Intervention: DTPa‐HBV/Hib
Number of subjects: 360

Group type: COMPARATOR
Intervention: DTPa‐HBV
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: DTPa‐HBV/Hib booster
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: PRP administered to lower responders
Number of subjects: 360
Study: 18162243

Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 70000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70000
Study: 16336071

Group type: EXPERIMENTAL
Intervention: Comprehensive family‐based behavioral treatment program
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Experimental treatment incorporating reinforcing children for engaging in alternative behaviors to eating
Number of subjects: 54

Group type: COMPARATOR
Intervention: Activities that compete with eating (within-subject design)
Number of subjects: 54
Study: 12490092

Group type: EXPERIMENTAL
Intervention: High-dose group received a primary dose of 1000 units of the new vaccine.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Low-dose group received a primary dose of 500 units of the new vaccine.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Havrix group received a primary dose of 1440 enzyme-linked immunosorbent assay units of Havrix.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High-dose group (1000 units) at month 6.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High-dose group (1000 units) one month after booster dose.
Number of subjects: 104